Tag Archives: Nadja Scherbakov

Research: Tolerability & efficacy of s.c. IgG self-treatment in ME/CFS patients with IgG/IgG subclass deficiency

Posted on 07/13/2021 by wames

Tolerability and efficacy of s.c. IgG self-treatment in ME/CFS patients with IgG/IgG subclass deficiency: a proof-of-concept study, by Carmen Scheibenbogen, Franziska Sotzny, Jelka Hartwig, Sandra Bauer, Helma Freitag, Kirsten Wittke, Wolfram Doehner, Nadja Scherbakov, Madlen Loebel, Patricia Grabowski in J … Continue reading →

Posted in News | Tagged , , , , , , , , , , , | Comments Off on Research: Tolerability & efficacy of s.c. IgG self-treatment in ME/CFS patients with IgG/IgG subclass deficiency

Peripheral endothelial dysfunction in ME/CFS

Posted on 03/19/2020 by wames

Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome, by Nadja Scherbakov, Marvin Szklarski, Jelka Hartwig, Franziska Sotzny, Sebastian Lorenz, Antje Meyer, Patricia Grabowski, Wolfram Doehner, Carmen Scheibenbogen in ESC Heart Failure, 10 March 2020  [https://doi.org/10.1002/ehf2.12633]   Research abstract: Aims: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Peripheral endothelial dysfunction in ME/CFS